National Council on Aging Talks Hair Loss with Dr. Green
The NCOA (National Council on Aging) article this week outlines Hers as a comprehensive telehealth-based hair loss treatment platform specifically geared toward women, offering both over-the-counter and prescription options. The brand’s product lineup includes shampoos and conditioners, oral supplements and gummies, topical serums and foams, and prescription medications that may contain FDA-approved active ingredients like minoxidil and finasteride. Hers uses a personalized care model where users can take a free hair quiz and consult with licensed health care providers to tailor treatments to their needs, with many users reporting reduced shedding and thicker hair after three to six months of consistent use.
The article also explains how different products are intended to work: minoxidil-containing formulas stimulate hair follicles and can be effective for early to moderate hair thinning, while biotin-enriched shampoos and conditioners focus primarily on cosmetic improvements like strength and volume. Side effects can occur, particularly with minoxidil (e.g., scalp irritation, unwanted body hair), so consulting a health care provider before starting treatment is advised. NCOA testers appreciated the breadth of Hers’s offerings—from simple supplements to more intensive prescription regimens—but noted that navigating the product range can be a bit complex since recommended options often direct users rather than browsing the full catalog.
Dr. Green is quoted in the article including her note about how “hair loss can be distressing, and many individuals want a quick fix to regrow their hair. Unfortunately, hair growth is very slow, and individuals may not see any new hair growth until at least four months after beginning a treatment. It is important to allow the treatment to work for at least four months before determining its effectiveness for hair regrowth” – read more at https://www.ncoa.org/product-resources/hair-loss/hers-hair-growth-review/